Peer Review History
| Original SubmissionMay 19, 2022 |
|---|
|
PONE-D-22-14610Cohort profile: The ENTWINE iCohort Study, a multinational longitudinal web-based study of informal carePLOS ONE Dear Dr. Elayan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. First of all, I sincerely apologize for the delay in my response. Unfortunately, it was initially difficult to secure reviewers. Furthermore, several candidates who had initially accepted the task later stepped down, without delivering their reports. Please find the attached reports. Overall, both reviewers have provided positive evaluations of your contribution. However, they have also offered suggestions and requested clarifications that can help improve the paper. I kindly ask you to thoroughly read both reports and address the comments mentioned therein. If you are willing to do this, we will be ready to reconsider the paper for publication. Please submit your revised manuscript by Aug 10 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Matteo Lippi Bruni, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. During our internal checks, the in-house editorial staff noted that you conducted research or obtained samples in another country. Please check the relevant national regulations and laws applying to foreign researchers and state whether you obtained the required permits and approvals. Please also state whether you approached an institutional review board (ethics committee) in Poland, Ireland and Greece before the study began. Please address this in your ethics statement in both the manuscript and submission information. In addition, please ensure that you have suitably acknowledged the contributions of any local collaborators involved in this work in your authorship list and/or Acknowledgements. Authorship criteria is based on the International Committee of Medical Journal Editors (ICMJE) Uniform Requirements for Manuscripts Submitted to Biomedical Journals - for further information please see here: https://journals.plos.org/plosone/s/authorship. 3. Please amend your current ethics statement to address the following concerns: a) Did participants provide their written or verbal informed consent to participate in this study? b) If consent was verbal, please explain i) why written consent was not obtained, ii) how you documented participant consent, and iii) whether the ethics committees/IRB approved this consent procedure. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 6. Ethics statement appears in the Methods section of the manuscript AND at the end of the manuscript: Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary The paper presents the baseline cohort of the “ENTWINE iCohort Study” and accurately describes its design, recruitment methods, data collection procedures, measures, and early baseline statistics. The survey was conducted in nine European countries, namely Germany, Greece, Ireland, Israel, Italy, the Netherlands, Poland, Sweden, and the United Kingdom. The study comprised a web-based longitudinal survey (baseline + 6-month follow-up) and optional weekly diary assessments, conducted separately with caregivers and care recipients. Moreover, authors show a set of descriptive statistics of the respondents, focusing on the sample of caregivers and care-recipients separately. General Comments I think that the information collected in the survey may have potential for future research in the field. For instance, modules such as (i) cultural and psychosocial aspects and (ii) interpersonal processes are really interesting and not usually included in the existing international surveys on this topic. Moreover, information on perceived gains and caregiving burden may be useful to “measure” the pressure to which caregivers are exposed in doing their activities. Even though I see potential for this work, there are some points which need a more in-depth discussion. In what follows I shall try to summarize my main comments. 1. The manuscript was classified as a “Research article”, but it describes in detail a new dataset, providing to the reader some descriptive statistics on the baseline data without answering any research questions. Honestly, I think it should be classified more properly as a presentation of a new database. 2. Authors write at p. 33: “By design, and due to time and budget constraints, representative samples of caregivers and care recipients were not sought. However, best efforts were made to recruit diverse samples in order to capture the caregiving experiences of participants with different characteristics and care situations. Despite these efforts, females were overrepresented in both the caregiver and care recipient samples. However, this overrepresentation of females is consistently observed in studies on informal care [92–94] and reflects their actual dominance in informal care provision according to European statistics [13,95] and their greater willingness to participate in surveys in general [96,97]. The lack of representativeness in our samples can compromise the estimation of descriptive population parameters (i.e., population means and proportions) [98]. However, the estimation of association patterns, which is the main goal of the present study, is relatively robust to the bias introduced by the lack of representativeness [99]. In fact, it has been reported that with appropriate controlling for confounding only an extreme case of this bias can obscure association patterns [99] and apart from this particular case, a representative sample might not be needed [100] or desired [101]” Personally, I think that having a representative sample is quite relevant in general. However, I recognize that some literature (cited in the paper) supports the thesis of the non-representativeness of the sample in specific cases. Turning to what the authors claim above, it is not clear to me in particular this part: “The lack of representativeness in our samples can compromise the estimation of descriptive population parameters (i.e., population means and proportions) [98]. However, the estimation of association patterns, which is the main goal of the present study, is relatively robust to the bias introduced by the lack of representativeness” I would kindly ask the authors to explain this part more clearly. I do not understand what they refer to when they mention “association patterns”. In the paper, I see only descriptive statistics, for which the lack of representativeness may be an issue… 3. As mentioned by the authors, the information on caregiving was collected in a very “special” period, during the first waves of the Covid-19 pandemics. They discuss in the text strengths and limitations related to the timing of the survey, claiming that some groups of participants might have experienced significant changes to their caregiving and care receiving experiences due to COVID-19 restrictive measures. Moreover, caregivers and in particular care recipients are among the most vulnerable groups in the population, and were more exposed to the negative consequences of the pandemics. Due to the peculiarity of the period, it should be very helpful to have further rounds of data that allow to look at the long-term patterns of informal caregiving. 4. I would include in the paper some indications concerning the availability of the dataset. Is it publicly accessible? Where? As highlighted in the “Submission Guidelines” of the Journal, “the database must be open-access and hosted somewhere publicly accessible”. Minor: • p. 6 line 111: “MH, VM, RS, and NV”: These acronyms are not explained before in the text. Please clarify the meaning. Reviewer #2: The paper describes the design, recruitment methods, data collection procedures, measures, and early baseline findings of the cohort study. The authors adopted ENTWINE icohort Study. The analysis involves 9 countries and studies the period from 14 August 2020 to 31 August 2021. In the complex, the paper is well-written and well-finished in each section, I just recommend some modifications or further clarification that could ameliorate the work. Line 125. I suggest the authors to better explain if August 2020-December 2021 is the baseline period only or if it included also the 6 months of follow-up. Anyway, it resulted in conflict with the study period indicated in the abstract. Or just refer to the dedicated section. Line 242. It is not clear when the recruitment phase ended: that is, is it staggered recruitment? Are there people who had completed the baseline survey while others still have to be recruited? Line 249. How are classified people who choose "none of the above", were drop from the sample? Section “Baseline cohort characteristics”. -I suggest adding information about some indices included in the analyses, such as "WHO-5 score" and "Katz ADL index", in particular, if they were somehow calculated or retrieved somewhere (in the survey or elsewhere). -It is not clear if follow-up phases are ended too. Consequently, aren't the results of follow-up surveys and (optional) weekly diary assessments available yet? Are they not presented in the results paragraph? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Cohort profile: The ENTWINE iCohort Study, a multinational longitudinal web-based study of informal care PONE-D-22-14610R1 Dear Dr. Elayan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Matteo Lippi Bruni, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I thank the authors for the serious work incorporating my suggestions into the paper. I enjoyed reading the revised version. Other than that, I think the paper is ready for publication. Reviewer #2: The authors revised the manuscript "Cohort profile: The ENTWINE iCohort Study, a multinational longitudinal web-based study of informal care" on the base of reviewers' comments. The new version better meets the indications and suggestions. Concerning the previous comments and recommendations, I consider that the authors made a work on the paper that returns a clearer and more readable analysis. In regards to responses to comments 1-2-5, in the new version submitted all issues related to periods (base period, recruitment period, and follow-up) are been cleared and better explained. And also all related questions about staggered recruitment and the content of the results discussion. The added sentence about the "None of the above" (response to comment 3) allows the reader to identify and understand the category. The additional information about indices employed in the analysis supports in the reading and understanding. I appreciate the extension of the section related to information about the Katz index and WHO-5 (and integration in footnotes). As concerned with the work in the complex and the structure of the manuscript, I agree with the issue raised by reviewer #1 concerning the classification of the manuscript as a “Research article”. I consider that, since it mainly consists of a detailed description of a new dataset, it should be identified and reclassified as a presentation of a new database. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-14610R1 PLOS ONE Dear Dr. Elayan, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Matteo Lippi Bruni Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .